Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R)

INTRODUCTION: Osteosarcoma overall survival has plateaued around 70%, without meaningful improvements in over 30 years. Outcomes for patients with overt metastatic disease at presentation or who relapse are dismal. In this study we investigated a novel osteosarcoma therapy utilizing radioimmunothera...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Nucl Med Biol
Main Authors: Geller, David S., Morris, Jonathan, Revskaya, Ekaterina, Kahn, Mani, Zhang, Wendong, Piperdi, Sajida, Park, Amy, Koirala, Pratistha, Guzik, Hillary, Hall, Charles, Hoang, Bang, Yang, Rui, Roth, Michael, Gill, Jonathan, Gorlick, Richard, Dadachova, Ekaterina
Format: Artigo
Sprog:Inglês
Udgivet: 2016
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5118104/
https://ncbi.nlm.nih.gov/pubmed/27744117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nucmedbio.2016.07.008
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker